Profil
Kurt W.
Briner formerly worked at Sanofi, as President & Chief Executive Officer in 2000, Sanofi AG, as President & Chief Executive Officer from 1988 to 1998, Progenics Pharmaceuticals, Inc., as Independent Director from 2011 to 2013, Novo Nordisk A, as Director, Vifor Pharma AG, as Non-Executive Director from 2013 to 2014, Vifor Pharma Management AG, as Director, Galenica SA, as Director, and BioAmber, Inc., as Independent Director from 2012 to 2018.
Anciens postes connus de Kurt W. Briner
| Sociétés | Poste | Fin |
|---|---|---|
| BIOAMBER INC. | Chairman | 01/02/2012 |
| VIFOR PHARMA | Director/Board Member | 08/05/2014 |
| PROGENICS PHARMACEUTICALS, INC. | Chairman | 14/06/2010 |
| NOVO NORDISK A/S | Director/Board Member | 18/03/2009 |
| SANOFI | President | 01/01/2000 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| SANOFI | Health Technology |
| Entreprise privées | 6 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Health Technology |
Galenica SA
 Galenica SA Pharmaceuticals: MajorHealth Technology Galenica SA provides pharmaceutical solutions. It develops medicines for sensory organs diseases, oncologicals, cardiologicals, dermatologicals, anti-osteoporosis medications, vertigo and vomiting, anti-diarrhea, anti-allergics and anti-inflammatories. The company was founded by Denis Varelas and Basile Tamvacas in 1974 and is headquartered in Athens, Greece. | Health Technology |
BioAmber, Inc.
 BioAmber, Inc. Chemicals: SpecialtyProcess Industries BioAmber, Inc. is an industrial biotechnology company, which produces sustainable chemicals. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in everyday products, including plastics, resins, paints, food additives and personal care products. The firm's products include bio-based succinic acid, butanediol and bio-based disodium succinate. The company was founded on October 15, 2008 and is headquartered in Montreal, Canada. | Process Industries |
| Sanofi AG |
